FRANKFURT (dpa-AFX) - Following a downgrade by Deutsche Bank, the Sartorius share price is likely to continue its downward trend on Thursday. On Tradegate, the preference shares lost a good two percent to 324 euros in relation to the Xetra close on the previous day.

Analyst Falko Friedrichs from Deutsche Bank justified the downgrade of the shares from "buy" to "hold" with a high valuation. Based on the estimates for 2025, the price/earnings ratio is 49, "which leaves no room for any disappointments". The continued destocking in the Bioprocess Solutions segment and the ongoing weakness in the laboratory business are a cause for concern.

From a technical perspective, the shares would close an upward gap from mid-December with prices below 317.40 euros. Prior to this, the 21-day line at just over EUR 322 provides support. The share recently failed several times at the round mark of EUR 350./bek/jha/